BRITTANY HASKIN: Open Payments
NPI 1083245559 · ELK RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,746 in 152 payments from 25 companies in 2025. Trend: 2023 $1,108 · 2024 $2,903 · 2025 $2,746
Food & beverage: $2,746
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $436 |
| AstraZeneca Pharmaceuticals LP | 13 | $323 |
| GlaxoSmithKline, LLC. | 16 | $267 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $203 |
| PFIZER INC. | 10 | $201 |
| Lilly USA, LLC | 9 | $161 |
| Otsuka America Pharmaceutical, Inc. | 11 | $155 |
| Novo Nordisk Inc | 5 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $107 |
| Aimmune Therapeutics, Inc. | 5 | $107 |
Products named: REXULTI, UBRELVY, CAPLYTA, TRELEGY ELLIPTA, AIRSUPRA, JARDIANCE, VRAYLAR, ZENPEP.
Industry payments across MI — which companies pay providers there.
